Article Text
Statistics from Altmetric.com
We read with great interest the epidemiological studies in inflammatory bowel disease (IBD) by Agrawal et al 1 and Cha et al 2 and would like to point out that the prevalence and natural history of IBD in the lesbian, gay, bisexual, transgender, queer (or questioning), intersex and asexual (or allies) (LGBTQIA+) population have not yet been reported.3 This is an important issue to address since, according to a 2022 Gallup poll, up to 7.1% of Americans identify as LGBTQIA+, up from 5.6% in 2020.4 In the present study, we used a large population-based database to evaluate the prevalence of Crohn’s disease (CD) and ulcerative colitis (UC) in LGBTQIA+ individuals, describe the demographic distribution of IBD in this patient population and evaluate their disease behaviour, as well as medical and surgical utilisation from a therapeutic perspective.
We evaluated data sourced from 58 healthcare organisations located within the USA (ie, TriNetX, a global federated health research network with waiver from Western Institutional Review Board (IRB)) over the last 20 years, from 2002 to 2022. Adult patients (aged>18 years) were first identified based on self-reported sexual orientation, including those identifying as heterosexual or homosexual, and then further …